“…A possible mechanism underlying the blockade of glucocorticoid-induced apoptosis by recombinant IL-2 is its capacity to initiate the proliferative cascade by JAK/STAT, PI3K, or MAPK signal pathways converging on the regulation of the expression of bcl-2 gene; up-regulation of bcl-2 gene expression results in cell survival and proliferation [6]. This assumption is confi rmed by a well-known capacity of glucocorticoids to inhibit the synthesis of antiapoptotic [2] and stimulate the synthesis of proapoptotic Bcl-2 family proteins [6,15], which leads to activation of the apoptotic program in the cell [11]. Moreover, we previously showed that binding of STAT5 and AP 1 proteins activated by IL-2 to glucocorticoid receptor prevents the formation of complexes of these receptors with cofactors CBP/ p300 or SRC-1a, which blocks the transduction of the proapoptotic signal [3] Mitochondrial factors (cytochrome C, AIF, calcium ions, Apaf-1, etc.)…”